Breaking News

What Covid's 'new normal' means, how certain UTI procedures affect children, & why private equity is jazzed about cardiology

September 11, 2023
Reporter, Morning Rounds Writer
Good morning. STAT's Helen Branswell and Matthew Herper will be watching the FDA to see if it authorizes new Covid vaccine boosters today. That's to be expected, but so is the current spike of cases, Helen writes in today's story about Covid's "new normal."

pandemic

Covid cases are rising again. We should get used to it 

The recent increase in Covid-19 activity has been accompanied by an equal if not greater increase in Covid coverage and Covid concern. While the angst is understandable, there's a reality we need to grasp about our coexistence with the SARS-CoV-2 virus: This is our life now, STAT's Helen Branswell reports. Sporadic increases in Covid transmission are going to keep occurring. Based on the past few years, it seems reasonable to conclude that cases will tick up at the end of the summer, as they are doing now. But contextualizing what's going on is important, experts tell STAT. The current increase in hospitalizations is less than half the size of the increase last year at this point, and roughly one-fifth the size of the increase seen at the end of August 2021.

Overusing words like surge can cause people to tune out of what's going on, some experts warn, potentially making it more difficult to resort to disease control measures down the road, when the next pandemic occurs. The job now is to figure out how we live with Covid as one of mix of respiratory viruses that come at us at a point or points every year. We have no choice. "I see so many people say: 'Remember, Covid's not over,'" Jennifer Nuzzo, an epidemiologist and director of Brown University's Pandemic Center, told Helen. "Covid's never going to be over. You need to set expectations accordingly. It is never going to be over."


Business

Private equity firms are buying up procedure-driven cardiology practices

More than a dozen years ago I wrote about a study that found heart patients overestimated how much stents would help them, believing they'd prevent heart attacks instead of just relieve chest pain. That perception meshes with a health system that prefers and highly rewards procedures, which rhymes with coronary stenting's rank as perhaps the most overused procedure in hospitals. Now, along with an estimated $500 million cost to that system and exposure to unnecessary risks for patients, there's another factor to consider. 

Private equity firms are getting into the game, racing to buy up and resell cardiology practices at a profit, STAT's Tara Bannow tells us, now that Medicare allows doctors do coronary procedures in ambulatory surgery centers. "They see dollar signs and they're going for them," said Vikas Saini of the Lown Institute. Roger Strode, who works on these deals, might agree. "Cardiology is starting to become one of the darlings of private equity," he said. Read more.


politics

NIH nominee Bertagnolli will get her confirmation hearing next month

Monica Bertagnolli, President Biden's nominee to lead the NIH, will get her long-awaited confirmation hearing next month, Sen. Bernie Sanders has promised. His health committee oversees such confirmations, but the Vermont Independent had held up the hearing until the Biden administration promised more action on drug pricing. Sen. Elizabeth Warren (D-Mass.) had also withheld her support for Bertagnolli's nomination until her ethics demands were met. Bertagnolli agreed to not join pharma or accept payment from the drug industry until at least four years after leaving government.

What appeared to change Sanders' mind? A deal with Regeneron, STAT's John Wilkerson reports. "I welcome the Biden administration's announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries," Sanders said in a release.



Closer Look

A commonly used test to diagnose UTIs in kids can leave a traumatic legacy

stat_9_8_2023

Maria Fabrizio for STAT

The decades-old practice is a mainstay in diagnosing and treating recurrent urinary tract infections in kids. But it's not hard to imagine how it might have a profound and traumatic effect on a child to be restrained, without sedation, while a physician threads a catheter up the urinary tract. The child then must urinate while lying on a table while imaging captures the process. "Until I got my medical records, I had always just remembered it in the form of a nightmare," said Shelby Smith, now 28, who launched a grassroots group that raises awareness about the test and hosts support groups.

The procedure works well to diagnose vesicoureteral reflux, which affects 1 in 4 children with UTIs and can lead to kidney failure if untreated. Some physicians do offer sedation, and newer tools include one that at least allows parents to hold their children, who urinate sitting down. STAT contributor Max Bennett has more, including where research is heading.   


infectious disease

Turmoil at ProMED continues, with its future in doubt

STAT's Helen Branswell brings this report: Today was meant to be the day ProMED resumed normal operations after a five-week strike by the experts who operate the global infectious diseases surveillance system. But the future of the venerated program remains in doubt. Over the weekend a number of moderators wrote to Paul Tambyah, chair of the executive committee of the International Society for Infectious Diseases, to say they will not return to work until a decision taken late last week to fire three moderators is reversed. (STAT learned Sunday that two additional moderators have been told their contracts have been terminated.)

In going to Tambyah, the still-striking moderators went over the head of the society's CEO, Linda MacKinnon, who fired the moderators, the leaders of the strike. "Actions and decisions like the termination jeopardize the future of the ProMED that we all care about," Tom Yuill, a professor emeritus at the University of Wisconsin-Madison, and a 16-year ProMED veteran who was not fired, wrote to Tambyah in explaining his decision to remain on strike. Yuill called the firings "vengeful retribution."

There are efforts afoot to try to find ProMED a new home and secure funding, something the ISID has struggled to provide over the past couple of years. But it is unclear how the continuing turmoil will affect ongoing talks. STAT has reached out to Tambyah, a professor of medicine at the National University of Singapore, for comment on the firings. He has not responded.


infectious disease

Midwinter report: Flu shots are performing well in South America

Here's some promising news: It looks like the 2023 flu vaccine formulation might perform better this winter than it has in some others. Early data from South America say flu-related hospitalizations were 52% lower for children and adults who got their flu shots than for those who didn't. The CDC warns us not to count on our flu season to exactly mimic what's happening midwinter in the Southern Hemisphere, but if similar flu viruses spread and predominate in the U.S. during our flu season, our vaccines could provide similar protection against severe illness that requires hospital care this fall and winter.

In still other vaccine news, a study in JAMA Network Open more says getting a flu shot and a bivalent Covid booster at the same time didn't lower immune response or cause troubling side effects any more than getting either shot alone.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved, STAT
  • Our big brains have shrunk. Scientists might know why, Wall Street Journal
  • Her work paved the way for blockbuster obesity drugs. Now, she's fighting for recognition, Science
  • Lawsuit raises antitrust and kickback allegations around cancer patient referrals, STAT
  • 'The US is an outlier': Will Mexico's abortion ruling drive Americans across the border? The Guardian
  • Obesity-related cardiovascular deaths tripled in the last two decades, new study finds, STAT

Thanks for reading! More tomorrow,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments